News, Analysis & Insights on Nutrition, Supplements, and Health
Evolutec, the British biotechnology company which develops novel therapeutic products from parasites, is to begin Phase I and II clinical trials with rEV131, its treatment for allergic and inflammatory diseases.
PC-SPES, a dietary supplement taken by some men to treat prostate cancer, may compromise the effectiveness of chemotherapeutic drugs for the disease, such as paclitaxel, according to a new study.
Consumption of garlic, chives, and other allium vegetables may be associated with a reduced risk of prostate cancer, according to a study carried out by researchers in Shanghai, China.
Cannabis-based medicine could be on the UK market as early as 2003, according to GW Pharmaceuticals, the UK company developing cannabis-based prescription medicines, which this week released results from four Phase III clinical trials.
The University of Leicester in the UK has been selected as one of the first centres in the world to trial a revolutionary new cancer prevention drug, based on a natural compound found in red wine.